Gastroscopy Clinical Trial
— FAREOfficial title:
Performance of a Single-use Gastroscope (aScope Gastro) for Esophagogastroduodenoscopy
Verified date | February 2024 |
Source | Erasmus Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Several infectious outbreaks have been described in the literature as a result of contaminated endoscopes. These endoscopes cannot be sterilized and require an extensive cleaning process in which breaches of cleaning protocols, endoscope damage or the formation of biofilm can prevent proper disinfection. The risk of endoscopy associated infection (EAI) and colonization due to contaminated endoscopes is still considered to be low. However, it is likely that there is severe underreporting of outbreaks due to a lack of recognition or assuming an infection to be endogenous. Due to the sheer volume of upper-gastrointestinal endoscopy worldwide, even with a low risk of EAI, the number of affected patients is significant. In response, several manufacturers have turned to the production of single-use endoscopes that eliminate the risk of exogenous infections. There are single use duodenoscopes on the market that almost seem to match the performance of reusable duodenoscopes. A new single use sterile gastroscope, Ambu aScope gastro, has been developed whose performance has not been previously described in patients. This multicenter single arm consecutive case series study will test the performance of these single use gastroscopes in patients undergoing esophagogastroduodenoscopy.
Status | Completed |
Enrollment | 60 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Subject is planned to undergo gastroscopy for any indication either outpatient or inpatient - The subject is = 18 years old Specifically for the Netherlands: - The subject is capable to understand the information required to give informed consent Exclusion Criteria: - Terminally ill patients - Patients whose condition in the opinion of the investigator would interfere with adequately assessing the study outcomes - Patients that participate in other investigational studies which would interfere with the outcomes of this study |
Country | Name | City | State |
---|---|---|---|
Netherlands | Erasmus Medical Center | Rotterdam | Zuid Holland |
Norway | Oslo University Hospital - Rikshospitalet | Oslo |
Lead Sponsor | Collaborator |
---|---|
Erasmus Medical Center | Ambu A/S, Maag Lever Darm Stichting |
Netherlands, Norway,
ASGE Standards of Practice Committee; Ben-Menachem T, Decker GA, Early DS, Evans J, Fanelli RD, Fisher DA, Fisher L, Fukami N, Hwang JH, Ikenberry SO, Jain R, Jue TL, Khan KM, Krinsky ML, Malpas PM, Maple JT, Sharaf RN, Dominitz JA, Cash BD. Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012 Oct;76(4):707-18. doi: 10.1016/j.gie.2012.03.252. No abstract available. — View Citation
Bajolet O, Ciocan D, Vallet C, de Champs C, Vernet-Garnier V, Guillard T, Brasme L, Thiefin G, Cadiot G, Bureau-Chalot F. Gastroscopy-associated transmission of extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa. J Hosp Infect. 2013 Apr;83(4):341-3. doi: 10.1016/j.jhin.2012.10.016. Epub 2013 Jan 20. — View Citation
McCafferty CE, Aghajani MJ, Abi-Hanna D, Gosbell IB, Jensen SO. An update on gastrointestinal endoscopy-associated infections and their contributing factors. Ann Clin Microbiol Antimicrob. 2018 Oct 10;17(1):36. doi: 10.1186/s12941-018-0289-2. — View Citation
Ofstead CL, Buro BL, Hopkins KM, Eiland JE, Wetzler HP, Lichtenstein DR. Duodenoscope-associated infection prevention: A call for evidence-based decision making. Endosc Int Open. 2020 Dec;8(12):E1769-E1781. doi: 10.1055/a-1264-7173. Epub 2020 Nov 17. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Performance of a single use gastroscope, Ambu aScope gastro, for esophagogastroduodenoscopy | Is the endoscopist able to complete the desired diagnostics/therapeutics during the EGD | 4 months | |
Secondary | Qualitative assessment of the single-use gastroscope | Qualitative assessment of the single-use gastroscope, Ambu aScope gastro, compared to the experience only having used re-usable devices by means of a questionnaire answered by the endoscopist post-EGD. The following characteristics will be rated on a 5 point Likert scale ranging from "much worse" to "much better":
Ease of intubation Ease of intubating duodenum Completeness of inspection of the upper digestive track Image quality Handling Lighting Color reproduction Air delivery Therapeutics |
4 months | |
Secondary | Complications of EGD | Complications of EGD including pain post-EGD, bleeding, perforation, and 30-day post-gastroscopy infection rates | 4 months | |
Secondary | Incidence of switching to reusable endoscope | 4 months | ||
Secondary | Time to complete procedure | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01350050 -
Topical Pharyngeal Anesthesia With Articaine for Gastroscopy
|
Phase 4 | |
Completed |
NCT04292496 -
Anastomotic Leak Testing in Gastrectomy
|
N/A | |
Completed |
NCT05219136 -
Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol
|
N/A | |
Completed |
NCT04150237 -
Using Simulation to Ensure Basic Competence in Gastroscopy
|
||
Completed |
NCT05012527 -
Retrospective Review of Gastrointestinal System Endoscopy Procedures
|
||
Recruiting |
NCT05965921 -
Real-life Prospective Evaluation of Computer-aided Detection (CAD) of Barrett's Neoplasia
|
||
Completed |
NCT02576340 -
Spasmolytic in Upper Gastrointestinal Endoscopy
|
Phase 4 | |
Completed |
NCT01154530 -
Chlorhexidine Mouthwash and Bacterial Contamination During Endoscopy
|
N/A | |
Completed |
NCT05773807 -
Effect of Bispectral Index Monitoring (BIS) on Body Movement of Outpatients Undergoing Gastroscopy
|
N/A | |
Completed |
NCT04247399 -
Simulation-assisted Teaching in Learning Gastroscopy
|
N/A | |
Not yet recruiting |
NCT05693298 -
High Flow Nasal Cannula in Patients Undergoing Gastroscopy
|
N/A | |
Completed |
NCT04682821 -
The Research of AI Assistant Gastroscope Training
|
N/A | |
Completed |
NCT01151228 -
Bedside Ultrasound Assessment of Gastric Content and Volume
|
N/A | |
Recruiting |
NCT04641455 -
Use of Mucolytic Solution Before Upper Endoscopy
|
N/A | |
Not yet recruiting |
NCT06303037 -
Effect of Esketamine on 95% Induction Dose of Remimazolam
|
Phase 4 |